Research progress on drug resistance mechanism of Candida glabrata / 药学实践与服务
Journal of Pharmaceutical Practice and Service
; (12): 393-395, 2023.
Article
em Zh
| WPRIM
| ID: wpr-978474
Biblioteca responsável:
WPRO
ABSTRACT
With the increasing proportion of Candida glabrata in patients with candidiasis, C. glabrata has become one of the most common pathogenic Candida in clinical practice. There are limited types of antifungal drugs, and the consequent problem of drug resistance is severely increasing, which brings difficulties to clinical treatment. The resistance mechanisms of C. glabrata to azoles, echinocandins and polyenes were reviewed in this paper.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Pharmaceutical Practice and Service
Ano de publicação:
2023
Tipo de documento:
Article